all the information, none of the junk | biotech • healthcare • life sciences

FDA Gives Highest Priority to CareFusion Recall

San Diego-based CareFusion (NYSE: CFN) says the FDA has assigned its most serious classification to a recall the company issued in August for an electronic intravenous infusion pump. The company says a glitch that causes the unit to freeze could cause “serious adverse health consequences or death.” The medical device maker, which was spun out of Ohio’s Cardinal Health last year, says it is recalling model 8015 of the Alaris PC unit made between December 2008 and September 2009. CareFusion says certain wireless network conditions can cause intermittent communication errors that freeze the unit’s display screen.